COVID-19
The CRF has supported many COVID-19 related studies over the past year. These studies range from investigator led studies where we are trying to understand more about the disease and how it affects people to clinical trials where we are trying to determine the best treatment for patients in either an inpatient or intensive care setting.
| Study Name | Study Title Study | Study Type | Sponsor | Sponsor Type |
|---|---|---|---|---|
| SOLIDARITY | An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care (Public health emergency SOLIDARITY trial) | Clinical trial | WHO | Non-commercial: Hospital |
| REMAP-CAP | Randomized, Embedded, Multifactorial Adaptive Platform trial for Community Acquired Pneumonia | Clinical trial | University Medical Center Utrecht | Academic |
| Alfa-1 | A randomized double blind placebo- controlled, pilot trial of intravenous plasma-purified alpha 1 antitrypsin for severe COVID-19 illness | Clinical trial | RCSI | Academic |
| STARR Bio-resource | COVID-19 Bioresource Characterising the immune response in Covid-19 infection. | Observational | Academic | Non-commercial: Academic |
| Covid Encephalopathy | Analysing blood-brain barrier integrity to inform on protection from CoVID-19 associated encephalopathy. | Observational | Academic | Non-commercial: Academic |